This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2004-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2008
Title: Innovations of Jianping Huang
Introduction
Jianping Huang is a notable inventor based in Carmel, IN (US), recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, Huang has made significant strides in developing compounds that target critical biological pathways.
Latest Patents
Huang's latest patents include innovative compounds such as 7-phenyl-isoquinoline-5-sulfonylamino derivatives, which serve as inhibitors of AKT (protein kinase B) activity. These compounds are particularly useful in treating susceptible neoplasms and viral infections. Another patent focuses on agents and methods for the treatment of proliferative diseases, providing selective kinase inhibitors that hold promise for advancing therapeutic options.
Career Highlights
Huang is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Huang has collaborated with esteemed colleagues such as Sajan Joseph and Rima Salim Al-Awar, who bring diverse expertise to their projects.
Conclusion
Jianping Huang's innovative work in the pharmaceutical field exemplifies the impact of targeted research on health and medicine. His patents reflect a commitment to advancing treatment options for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile